Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,456,522
+$397,465 QoQ
Shares Held
8,642
+7.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#349
of 768 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ODDO BHF ASSET MANAGEMENT SAS holds $7,540,261 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
84,661 | $6,083,739 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
8,642 | $1,456,522 | |
| 3 | 5,000,000 | $0 |
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,456,522 | 8,642 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,059,057 | 8,039 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,080,744 | 7,620 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $788,935 | 5,620 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||